Shenzhen Zhijun pharmaceutical co., ltd.

Shenzhen Zhijun Pharmaceutical Co., Ltd., formerly known as Shenzhen Pharmaceutical Factory, was established in 1985. Zhijun Pharmaceutical is an important enterprise in the cephalosporin industrial chain of China Pharmaceutical Group and the core industrial enterprise of Shenzhen Yi Tong Pharmaceutical Co., Ltd.. After more than 20 years of efforts, Zhijun Pharmaceutical has developed into a total asset of nearly 6543. 800 million yuan, annual sales of more than 6543. 800 million yuan, the total profit exceeded 200 million yuan, and the total tax payment was nearly 6543. 800 million yuan of state-level high-tech enterprises. It ranks among the top 50 pharmaceutical companies in China, with more than 654.38+0.200 employees. Zhijun Pharmaceutical mainly develops, produces and sells anti-infection, respiratory and digestive system drugs and health care products. It has a modern pharmaceutical R&D and manufacturing base meeting international standards, covering an area of 42,000 square meters. It has six workshops and 65,438+00 production lines for powder injection, oral solid preparations (cephalosporins and non-cephalosporins) and oral solution preparations. It is the first manufacturer in China to register its own products for cephalosporin powder injection and pass the GMP certification of the European Union. By virtue of strict quality control system and strong marketing network, Zhijun Pharmaceutical has created a number of brand-name products with the highest market share, among which Dali Xin has become the leader of similar products, forming a boutique effect of the linkage between Dali series product brands and Zhijun enterprise brands, and gradually expanding its own brand market overseas and establishing an international brand. Looking forward to the future, Zhijun Medicine will integrate R&D and marketing, focus on anti-infection, respiratory system, digestive system, cardiovascular and cerebrovascular diseases, over-the-counter drugs and health care products, and become a medical and health product and service provider with leading quality, core competitive advantage, horizontal correlation diversification and brand influence in domestic and foreign markets.